Cargando…
Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
Solid serous cystadenoma (SCA) of the pancreas is a rare type of pancreatic solid tumors. Postoperative pathological evaluation is of particular importance for distinguishing solid SCA of the pancreas from other pancreatic solid tumors. Here we present 2 cases of solid SCA of the pancreas, both preo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554012/ https://www.ncbi.nlm.nih.gov/pubmed/25816032 http://dx.doi.org/10.1097/MD.0000000000000644 |
_version_ | 1782387992432738304 |
---|---|
author | Wu, Wenming Hong, Xiafei Li, Ji Dai, Menghua Wang, Wenze Tong, Anli Zhu, Zhaohui Dai, Hongmei Zhao, Yupei |
author_facet | Wu, Wenming Hong, Xiafei Li, Ji Dai, Menghua Wang, Wenze Tong, Anli Zhu, Zhaohui Dai, Hongmei Zhao, Yupei |
author_sort | Wu, Wenming |
collection | PubMed |
description | Solid serous cystadenoma (SCA) of the pancreas is a rare type of pancreatic solid tumors. Postoperative pathological evaluation is of particular importance for distinguishing solid SCA of the pancreas from other pancreatic solid tumors. Here we present 2 cases of solid SCA of the pancreas, both preoperatively diagnosed with pancreatic neuroendocrine tumors. One case had positive OctreoScan test. Surgical resections were done for both cases. Postoperative immunohistochemistry assays were conducted with marker panels for SCA and 2 types of pancreatic solid tumors, which were neuroendocrine tumor (pNET) and solid pseudopapillary tumor (SPT). Two cases showed typical staining patterns for SCA markers. Notably, both cases showed positivity for 4 SPT markers (vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin). Emphasis should be paid to those 4 new markers for future pathological diagnosis of solid SCA of the pancreas. |
format | Online Article Text |
id | pubmed-4554012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-45540122015-10-27 Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers Wu, Wenming Hong, Xiafei Li, Ji Dai, Menghua Wang, Wenze Tong, Anli Zhu, Zhaohui Dai, Hongmei Zhao, Yupei Medicine (Baltimore) 5700 Solid serous cystadenoma (SCA) of the pancreas is a rare type of pancreatic solid tumors. Postoperative pathological evaluation is of particular importance for distinguishing solid SCA of the pancreas from other pancreatic solid tumors. Here we present 2 cases of solid SCA of the pancreas, both preoperatively diagnosed with pancreatic neuroendocrine tumors. One case had positive OctreoScan test. Surgical resections were done for both cases. Postoperative immunohistochemistry assays were conducted with marker panels for SCA and 2 types of pancreatic solid tumors, which were neuroendocrine tumor (pNET) and solid pseudopapillary tumor (SPT). Two cases showed typical staining patterns for SCA markers. Notably, both cases showed positivity for 4 SPT markers (vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin). Emphasis should be paid to those 4 new markers for future pathological diagnosis of solid SCA of the pancreas. Wolters Kluwer Health 2015-03-27 /pmc/articles/PMC4554012/ /pubmed/25816032 http://dx.doi.org/10.1097/MD.0000000000000644 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial License, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 5700 Wu, Wenming Hong, Xiafei Li, Ji Dai, Menghua Wang, Wenze Tong, Anli Zhu, Zhaohui Dai, Hongmei Zhao, Yupei Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers |
title | Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers |
title_full | Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers |
title_fullStr | Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers |
title_full_unstemmed | Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers |
title_short | Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers |
title_sort | solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markers |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554012/ https://www.ncbi.nlm.nih.gov/pubmed/25816032 http://dx.doi.org/10.1097/MD.0000000000000644 |
work_keys_str_mv | AT wuwenming solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT hongxiafei solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT liji solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT daimenghua solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT wangwenze solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT tonganli solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT zhuzhaohui solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT daihongmei solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers AT zhaoyupei solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers |